Show simple item record

dc.contributor.authorTang, Benjamin C.
dc.contributor.authorWebber, Matthew
dc.contributor.authorLanger, Robert S
dc.contributor.authorKhan, Omar Fizal
dc.contributor.authorSydlik, Stefanie Arlene
dc.date.accessioned2016-08-30T21:40:58Z
dc.date.available2016-08-30T21:40:58Z
dc.date.issued2014-09
dc.date.submitted2014-07
dc.identifier.issn0090-6964
dc.identifier.issn1573-9686
dc.identifier.urihttp://hdl.handle.net/1721.1/104085
dc.description.abstractScaffolds have been broadly applied within tissue engineering and regenerative medicine to regenerate, replace, or augment diseased or damaged tissue. For a scaffold to perform optimally, several design considerations must be addressed, with an eye toward the eventual form, function, and tissue site. The chemical and mechanical properties of the scaffold must be tuned to optimize the interaction with cells and surrounding tissues. For complex tissue engineering, mass transport limitations, vascularization, and host tissue integration are important considerations. As the tissue architecture to be replaced becomes more complex and hierarchical, scaffold design must also match this complexity to recapitulate a functioning tissue. We outline these design constraints and highlight creative and emerging strategies to overcome limitations and modulate scaffold properties for optimal regeneration. We also highlight some of the most advanced strategies that have seen clinical application and discuss the hurdles that must be overcome for clinical use and commercialization of tissue engineering technologies. Finally, we provide a perspective on the future of scaffolds as a functional contributor to advancing tissue engineering and regenerative medicine.en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Ruth Kirschstein National Research Service Award (F32DK101335))en_US
dc.description.sponsorshipJuvenile Diabetes Research Foundation International (a Postdoctoral Fellowship (3-2011-310))en_US
dc.publisherSpringer USen_US
dc.relation.isversionofhttp://dx.doi.org/10.1007/s10439-014-1104-7en_US
dc.rightsCreative Commons Attribution-Noncommercial-Share Alikeen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/en_US
dc.sourceSpringer USen_US
dc.titleA Perspective on the Clinical Translation of Scaffolds for Tissue Engineeringen_US
dc.typeArticleen_US
dc.identifier.citationWebber, Matthew J., Omar F. Khan, Stefanie A. Sydlik, Benjamin C. Tang, and Robert Langer. “A Perspective on the Clinical Translation of Scaffolds for Tissue Engineering.” Ann Biomed Eng 43, no. 3 (September 9, 2014): 641–656.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Institute for Medical Engineering & Scienceen_US
dc.contributor.departmentHarvard University--MIT Division of Health Sciences and Technologyen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Chemical Engineeringen_US
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MITen_US
dc.contributor.mitauthorWebber, Matthewen_US
dc.contributor.mitauthorLanger, Roberten_US
dc.contributor.mitauthorKhan, Omar F.en_US
dc.contributor.mitauthorSydlik, Stefanie A.en_US
dc.contributor.mitauthorTang, Benjamin C.en_US
dc.relation.journalAnnals of Biomedical Engineeringen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2016-05-23T12:16:39Z
dc.language.rfc3066en
dc.rights.holderBiomedical Engineering Society
dspace.orderedauthorsWebber, Matthew J.; Khan, Omar F.; Sydlik, Stefanie A.; Tang, Benjamin C.; Langer, Roberten_US
dspace.embargo.termsNen
dc.identifier.orcidhttps://orcid.org/0000-0003-3811-2369
dc.identifier.orcidhttps://orcid.org/0000-0003-0624-3532
dc.identifier.orcidhttps://orcid.org/0000-0003-4255-0492
mit.licenseOPEN_ACCESS_POLICYen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record